COCH, COCHW · CIK 0001840877 · operating
Envoy Medical, Inc. develops and markets hearing health technologies across the spectrum of hearing loss severity. The company's product portfolio includes personal sound amplification devices, conventional hearing aids, and surgically implantable solutions. Its implantable offerings comprise the Esteem fully implanted active middle ear implant, auditory osseointegrated implants for bone conduction hearing, and Acclaim cochlear implants for severe-to-profound hearing loss. These products are designed to address different patient populations and hearing loss profiles, from mild amplification needs to cases requiring surgical intervention.
The company operates with a team of 42 full-time employees and is headquartered in White Bear Lake, Minnesota. Envoy Medical trades on Nasdaq under the ticker COCHW and was incorporated in 1995, with a name change to its current designation in September 2023. The company distributes its products through hearing healthcare providers, though specific geographic market reach and revenue segment breakdowns are not currently detailed in available data.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.49 | $-1.49 | +37.4% | |
| 2023 | $-2.38 | $-2.38 | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — |